Stem cells in musculoskeletal engineered tissue

Current Opinion in Biotechnology

Volumn 20, Issue 5, 2009, Pages 537-544

  Deans, Tara L ^a   Elisseeff, Jennifer H ^a  

^a Johns Hopkins University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL;

ADULT STEM CELL; BIOMIMETICS; CELL DIFFERENTIATION; CELL ENCAPSULATION; CELL HOMING; CELL RENEWAL; EMBRYONIC STEM CELL; EXTRACELLULAR MATRIX; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; MUSCULOSKELETAL DISEASE; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; TISSUE ENGINEERING; TISSUE INTERACTION; TISSUE REPAIR;

ANIMALS; HUMANS; MUSCLE, SKELETAL; REGENERATION; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING;

EID: 71449117695     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.copbio.2009.10.005     Document Type: Review

References (46)

1. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., and Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998) 1145-1147
2. Wong D.J., Liu H., Ridky T.W., Cassarino D., Segal E., and Chang H.Y. Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell 2 (2008) 333-344
3. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., and Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
4. Kuo C.K., Li W.J., Mauck R.L., and Tuan R.S. Cartilage tissue engineering: its potential and uses. Curr Opin Rheumatol 18 (2006) 64-73
5. Tuan R.S., Boland G., and Tuli R. Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther 5 (2003) 32-45. A review that summarizes the biology of MSCs and their applications in tissue engineering.
6. Kern S., Eichler H., Stoeve J., Kluter H., and Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24 (2006) 1294-1301. A nice study comparing the ability of MSCs derived from bone marrow, umbilical cord blood, and adiopose tissue.
7. Kolambkar Y.M., Peister A., Soker S., Atala A., and Guldberg R.E. Chondrogenic differentiation of amniotic fluid-derived stem cells. J Mol Histol 38 (2007) 405-413
8. Kramer J., Hegert C., Guan K., Wobus A.M., Muller P.K., and Rohwedel J. Embryonic stem cell-derived chondrogenic differentiation in vitro: activation by BMP-2 and BMP-4. Mech Dev 92 (2000) 193-205
9. Hegert C., Kramer J., Hargus G., Muller J., Guan K., Wobus A.M., Muller P.K., and Rohwedel J. Differentiation plasticity of chondrocytes derived from mouse embryonic stem cells. J Cell Sci 115 (2002) 4617-4628
10. Hwang N.S., Varghese S., and Elisseeff J. Derivation of chondrogenically-committed cells from human embryonic cells for cartilage tissue regeneration. PLoS One 3 (2008) e2498
11. Hwang N.S., Varghese S., Lee H.J., Zhang Z., Ye Z., Bae J., Cheng L., and Elisseeff J. In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc Natl Acad Sci U S A 105 (2008) 20641-20646. The authors demonstrate that MSCs can be derived from embryonic stem cells to form functional tissue. Due to low numbers of endogenous MSCs, this is an alternative cell source to consider when designing delivery systems that contain therapeutic cells. These derived MSCs show no evidence of teratoma formation in vivo.
12. Olivier E.N., Rybicki A.C., and Bouhassira E.E. Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells. Stem Cells 24 (2006) 1914-1922
13. Liu Z.J., Zhuge Y., and Velazquez O.C. Trafficking and differentiation of mesenchymal stem cells. J Cell Biochem 106 (2009) 984-991. A review that discusses the release of MSCs from their niches and the signals involved with recruiting and trafficking these cells to the site of injury for repair.
14. Abarbanell A.M., Coffey A.C., Fehrenbacher J.W., Beckman D.J., Herrmann J.L., Weil B., and Meldrum D.R. Proinflammatory cytokine effects on mesenchymal stem cell therapy for the ischemic heart. Ann Thorac Surg 88 (2009) 1036-1043
15. Haider H., Jiang S., Idris N.M., and Ashraf M. IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circ Res 103 (2008) 1300-1308
16. Karp J.M., and Leng Teo GS. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 4 (2009) 206-216. A nice review focusing the methods used to track homing of infused MSCs. The authors also discuss ways to enhance trafficking to particular tissues.
17. Kavalkovich K.W., Boynton R.E., Murphy J.M., and Barry F. Chondrogenic differentiation of human mesenchymal stem cells within an alginate layer culture system. In Vitro Cell Dev Biol Anim 38 (2002) 457-466
18. Radice M., Brun P., Cortivo R., Scapinelli R., Battaliard C., and Abatangelo G. Hyaluronan-based biopolymers as delivery vehicles for bone-marrow-derived mesenchymal progenitors. J Biomed Mater Res 50 (2000) 101-109
19. Nuttelman C.R., Tripodi M.C., and Anseth K.S. In vitro osteogenic differentiation of human mesenchymal stem cells photoencapsulated in PEG hydrogels. J Biomed Mater Res A 68 (2004) 773-782
20. Williams C.G., Kim T.K., Taboas A., Malik A., Manson P., and Elisseeff J. In vitro chondrogenesis of bone marrow-derived mesenchymal stem cells in a photopolymerizing hydrogel. Tissue Eng 9 (2003) 679-688
21. Elisseeff J. Hydrogels: structure starts to gel. Nat Mater 7 (2008) 271-273
22. Hwang N.S., Varghese S., and Elisseeff J. Cartilage tissue engineering: directed differentiation of embryonic stem cells in three-dimensional hydrogel culture. Methods Mol Biol 407 (2007) 351-373
23. Hwang N.S., Varghese S., and Elisseeff J. Controlled differentiation of stem cells. Adv Drug Deliv Rev 60 (2008) 199-214
24. Gimble J.M., Zvonic S., Floyd Z.E., Kassem M., and Nuttall M.E. Playing with bone and fat. J Cell Biochem 98 (2006) 251-266
25. Heng B.C., Cao T., and Lee E.H. Directing stem cell differentiation into the chondrogenic lineage in vitro. Stem Cells 22 (2004) 1152-1167
26. Daley W.P., Peters S.B., and Larsen M. Extracellular matrix dynamics in development and regenerative medicine. J Cell Sci 121 (2008) 255-264. Discusses the dynamic behavior of the extracellular matrix and how this dynamic behavior is important to regulate cell proliferation, migration, and differentiation. This paper highlights the importance of considering the relationship between cells and their ECM for tissue regeneration.
27. Nehrer S., Breinan H.A., Ramappa A., Young G., Shortkroff S., Louie L.K., Sledge C.B., Yannas I.V., and Spector M. Matrix collagen type and pore size influence behaviour of seeded canine chondrocytes. Biomaterials 18 (1997) 769-776
28. Remacle M. Immune response after collagen injection for laryngeal rehabilitation: development of an enzyme-linked immunosorbent assay. Eur Arch Otorhinolaryngol 248 (1991) 376
29. Lee H.J., Lee J.S., Chansakul T., Yu C., Elisseeff J.H., and Yu S.M. Collagen mimetic peptide-conjugated photopolymerizable PEG hydrogel. Biomaterials 27 (2006) 5268-5276
30. Lee H.J., Yu C., Chansakul T., Hwang N.S., Varghese S., Yu S.M., and Elisseeff J.H. Enhanced chondrogenesis of mesenchymal stem cells in collagen mimetic peptide-mediated microenvironment. Tissue Eng Part A 14 (2008) 1843-1851
31. Mueller M.B., and Tuan R.S. Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells. Arthritis Rheum 58 (2008) 1377-1388
32. Lutolf M.P., and Hubbell J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 23 (2005) 47-55. Review on synthetic biomaterials that emphasizes the construction of sophisticated synthetic matrices.
33. Pratt A.B., Weber F.E., Schmoekel H.G., Muller R., and Hubbell J.A. Synthetic extracellular matrices for in situ tissue engineering. Biotechnol Bioeng 86 (2004) 27-36. PEG hydrogels were modified to create three-dimensional scaffolds that allowed for the scaffold to interact with cellular activity to include scaffold degradation based on cellular responses, cellular infiltration, and adhesion.
34. Sekiya I., Vuoristo J.T., Larson B.L., and Prockop D.J. In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis. Proc Natl Acad Sci U S A 99 (2002) 4397-4402
35. Tavella S., Bellese G., Castagnola P., Martin I., Piccini D., Doliana R., Colombatti A., Cancedda R., and Tacchetti C. Regulated expression of fibronectin, laminin and related integrin receptors during the early chondrocyte differentiation. J Cell Sci 110 Pt 18 (1997) 2261-2270
36. Hwang N.S., Varghese S., Zhang Z., and Elisseeff J. Chondrogenic differentiation of human embryonic stem cell-derived cells in arginine-glycine-aspartate-modified hydrogels. Tissue Eng 12 (2006) 2695-2706
37. Salinas C.N., and Anseth K.S. The influence of the RGD peptide motif and its contextual presentation in PEG gels on human mesenchymal stem cell viability. J Tissue Eng Regen Med 2 (2008) 296-304
38. Salinas C.N., Cole B.B., Kasko A.M., and Anseth K.S. Chondrogenic differentiation potential of human mesenchymal stem cells photoencapsulated within poly(ethylene glycol)-arginine-glycine-aspartic acid-serine thiol-methacrylate mixed-mode networks. Tissue Eng 13 (2007) 1025-1034
39. Nuttelman C.R., Tripodi M.C., and Anseth K.S. Synthetic hydrogel niches that promote hMSC viability. Matrix Biol 24 (2005) 208-218
40. Salinas C.N., and Anseth K.S. The enhancement of chondrogenic differentiation of human mesenchymal stem cells by enzymatically regulated RGD functionalities. Biomaterials 29 (2008) 2370-2377. Study shows how materials can be engineered to respond to the biological state of stem cells. Specifically, the authors incorporate an RGD molecule that contains an MMP-13 cleavable linker. As MSCs start to differentiate down the chondrogenic lineage, they release MMP-13, which cleaves the RGD from the hydrogel.
41. Mooney D.J., and Vandenburgh H. Cell delivery mechanisms for tissue repair. Cell Stem Cell 2 (2008) 205-213
42. Chen F.H., and Tuan R.S. Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther 10 (2008) 223
43. Caplan A.I. New era of cell-based orthopaedic therapies. Tissue Eng Part B Rev (2009)
44. Shapiro F., Koide S., and Glimcher M.J. Cell origin and differentiation in the repair of full-thickness defects of articular cartilage. J Bone Joint Surg Am 75 (1993) 532-553
45. Wang D.A., Varghese S., Sharma B., Strehin I., Fermanian S., Gorham J., Fairbrother D.H., Cascio B., and Elisseeff J.H. Multifunctional chondroitin sulphate for cartilage tissue-biomaterial integration. Nat Mater 6 (2007) 385-392
46. Mobasheri A., Csaki C., Clutterbuck A.L., Rahmanzadeh M., and Shakibaei M. Mesenchymal stem cells in connective tissue engineering and regenerative medicine: applications in cartilage repair and osteoarthritis therapy. Histol Histopathol 24 (2009) 347-366